NO20053748D0 - Pyrrolopyridazinderivater. - Google Patents

Pyrrolopyridazinderivater.

Info

Publication number: NO20053748D0
Authority: NO; Norway
Prior art keywords: pyrrolopyridazine derivatives; pyrrolopyridazine; derivatives
Prior art date: 2003-01-09

Application number

NO20053748A

Other languages

English (en)

Other versions

NO20053748L (no

Inventor

Kazuhiko Ohne

Yuki Sawada

Tsuyoshi Mizutani

Kenichiro Imamura

Yoshito Abe

Makoto Inoue

Kozo Sawada

Mitsuaki Okumura

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-09

Filing date

2005-08-04

Publication date

2005-08-04

2003-01-09 Priority claimed from AU2003900189A external-priority patent/AU2003900189A0/en

2003-07-14 Priority claimed from AU2003903628A external-priority patent/AU2003903628A0/en

2005-08-04 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

2005-08-04 Publication of NO20053748D0 publication Critical patent/NO20053748D0/no

2005-10-07 Publication of NO20053748L publication Critical patent/NO20053748L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Dermatology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO20053748A 2003-01-09 2005-08-04 Pyrrolopyridazinderivater. NO20053748L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AU2003900189A AU2003900189A0 (en)	2003-01-09	2003-01-09	Heterocyclic derivatives
AU2003903628A AU2003903628A0 (en)	2003-07-14	2003-07-14	Pyrrolopyridazine derivatives
PCT/JP2003/017091 WO2004063197A1 (en)	2003-01-09	2003-12-26	Pyrrolopyridazine derivatives

Publications (2)

Publication Number	Publication Date
NO20053748D0 true NO20053748D0 (no)	2005-08-04
NO20053748L NO20053748L (no)	2005-10-07

Family

ID=32714072

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053748A NO20053748L (no)	2003-01-09	2005-08-04	Pyrrolopyridazinderivater.

Country Status (22)

Country	Link
US (2)	US7153854B2 (no)
EP (1)	EP1581535B3 (no)
JP (1)	JP4671104B2 (no)
KR (1)	KR101026819B1 (no)
AR (1)	AR042833A1 (no)
AT (1)	ATE376549T1 (no)
BR (1)	BR0317358A (no)
CA (1)	CA2513081C (no)
CY (1)	CY1107084T1 (no)
DE (1)	DE60317102T3 (no)
DK (1)	DK1581535T5 (no)
ES (1)	ES2291729T7 (no)
HK (1)	HK1088900A1 (no)
IL (1)	IL169500A0 (no)
MX (1)	MXPA05007462A (no)
NO (1)	NO20053748L (no)
NZ (1)	NZ541232A (no)
PL (1)	PL378245A1 (no)
PT (1)	PT1581535E (no)
RU (1)	RU2328499C2 (no)
TW (1)	TWI332004B (no)
WO (1)	WO2004063197A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1581535B3 (en)	2003-01-09	2009-09-02	Astellas Pharma Inc.	Pyrrolopyridazine derivatives
US7030112B2 (en) *	2003-03-25	2006-04-18	Bristol-Myers Squibb Company	Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
WO2006004191A1 (en) *	2004-07-05	2006-01-12	Astellas Pharma Inc.	Pyrrolopyridazine derivatives which inhibit pde iv and tnf alfa
DE602005011286D1 (en) *	2004-07-05	2009-01-08	Astellas Pharma Inc	Pyrazolopyridinderivate
GB0422057D0 (en) *	2004-10-05	2004-11-03	Astrazeneca Ab	Novel compounds
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
CN101522682A (zh)	2006-10-30	2009-09-02	诺瓦提斯公司	作为抗炎剂的杂环化合物
JP2009114123A (ja) *	2007-11-06	2009-05-28	Astellas Pharma Inc	２−アシル−１−アミノピロール化合物の新規製造法
CA2722611A1 (en) *	2007-11-21	2009-05-28	Decode Genetics Ehf	Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
PL2231642T3 (pl)	2008-01-11	2014-04-30	Novartis Ag	Pirymidyny jako inhibitory kinazy
JPWO2009154230A1 (ja) *	2008-06-17	2011-12-01	持田製薬株式会社	非アルコール性脂肪肝炎の予防／改善・治療薬
US8703778B2 (en)	2008-09-26	2014-04-22	Intellikine Llc	Heterocyclic kinase inhibitors
WO2010059836A1 (en) *	2008-11-20	2010-05-27	Decode Genetics Ehf	Substituted aza-bridged bicyclics for cardiovascular and cns disease
AU2010241567B2 (en)	2009-04-29	2013-10-31	Amarin Pharmaceuticals Ireland Limited	Pharmaceutical compositions comprising EPA and a cardiovascular agent and methods of using the same
CA3091633A1 (en) *	2010-04-23	2011-10-27	Steam Tech, Llc	Surface wiper system
WO2011150356A1 (en) *	2010-05-28	2011-12-01	Biocryst Pharmaceuticals, Inc.	Heterocyclic compounds as janus kinase inhibitors
JP5888237B2 (ja)	2010-09-07	2016-03-16	アステラス製薬株式会社	ピラゾロキノリン化合物
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
MA34969B1 (fr)	2011-02-25	2014-03-01	Irm Llc	Composes et compositions en tant qu inibiteurs de trk
JP5988941B2 (ja) *	2012-09-20	2016-09-07	富士フイルム株式会社	有機銅錯体、有機銅錯体溶液、銅酸化物薄膜、銅酸化物薄膜の製造方法、および、化合物
US10434132B2 (en) *	2013-06-04	2019-10-08	Academia Sinica	Galactolipids-enriched plant extracts and the uses thereof
TWI695839B (zh) *	2017-11-17	2020-06-11	中央研究院	雙（羥甲基）吡咯并酞嗪混成物、其之製備方法與用途
EA202191046A1 (ru) *	2018-10-17	2021-07-12	Сувен Лайф Сайенсиз Лимитед	Производные пирролопиридазина, как позитивные аллостерические модуляторы мускаринового рецептора m1
SG11202109786UA (en)	2019-03-19	2021-10-28	Boehringer Ingelheim Animal Health Usa Inc	Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112022024156A2 (pt)	2020-05-29	2023-02-14	Boehringer Ingelheim Animal Health Usa Inc	Compostos heterocílicos antelmínticos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU7891891A (en)	1990-05-25	1991-12-31	Fujisawa Pharmaceutical Co., Ltd.	Pyrrolopyridazine compounds
WO1999059999A1 (fr)	1998-05-21	1999-11-25	Shionogi & Co., Ltd.	DERIVES DE LA PYRROLO[1,2-B] PYRIDAZINE, A EFFET INHIBITEUR SUR LE sPLA¿2?
IT1303272B1 (it) *	1998-10-29	2000-11-06	Zambon Spa	Derivati triciclici inibitori della fosfodiesterasi 4
FR2792938B1 (fr) *	1999-04-28	2001-07-06	Warner Lambert Co	NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
ATE414079T1 (de) *	2000-03-01	2008-11-15	Janssen Pharmaceutica Nv	2,4-disubstituierte thiazolyl derivate
AU2001267823A1 (en) *	2000-06-29	2002-01-08	Shionogi And Co., Ltd.	Compounds exhibiting x-type spla2 inhibiting effect
AU3276002A (en) *	2000-11-17	2002-05-27	Bristol Myers Squibb Co	Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
TWI312347B (en) *	2001-02-08	2009-07-21	Eisai R&D Man Co Ltd	Bicyclic nitrogen-containing condensed ring compounds
EP1426050A4 (en) *	2001-08-23	2005-05-25	Takeda Pharmaceutical	INHIBITORS OF JNK
US6900208B2 (en) *	2002-03-28	2005-05-31	Bristol Myers Squibb Company	Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
EP1581535B3 (en)	2003-01-09	2009-09-02	Astellas Pharma Inc.	Pyrrolopyridazine derivatives

2003
- 2003-12-26 EP EP03789642A patent/EP1581535B3/en not_active Expired - Lifetime
- 2003-12-26 JP JP2004566309A patent/JP4671104B2/ja not_active Expired - Fee Related
- 2003-12-26 MX MXPA05007462A patent/MXPA05007462A/es active IP Right Grant
- 2003-12-26 DE DE60317102T patent/DE60317102T3/de not_active Expired - Lifetime
- 2003-12-26 PL PL378245A patent/PL378245A1/pl unknown
- 2003-12-26 ES ES03789642T patent/ES2291729T7/es active Active
- 2003-12-26 KR KR1020057012805A patent/KR101026819B1/ko not_active IP Right Cessation
- 2003-12-26 BR BR0317358-5A patent/BR0317358A/pt not_active IP Right Cessation
- 2003-12-26 NZ NZ541232A patent/NZ541232A/en not_active IP Right Cessation
- 2003-12-26 PT PT03789642T patent/PT1581535E/pt unknown
- 2003-12-26 DK DK03789642T patent/DK1581535T5/da active
- 2003-12-26 CA CA2513081A patent/CA2513081C/en not_active Expired - Fee Related
- 2003-12-26 RU RU2005125209/04A patent/RU2328499C2/ru not_active IP Right Cessation
- 2003-12-26 AT AT03789642T patent/ATE376549T1/de active
- 2003-12-26 WO PCT/JP2003/017091 patent/WO2004063197A1/en active IP Right Grant
- 2003-12-30 US US10/747,079 patent/US7153854B2/en not_active Expired - Fee Related
2004
- 2004-01-08 TW TW093100400A patent/TWI332004B/zh active
- 2004-01-09 AR ARP040100063A patent/AR042833A1/es unknown
2005
- 2005-07-03 IL IL169500A patent/IL169500A0/en unknown
- 2005-08-04 NO NO20053748A patent/NO20053748L/no unknown
2006
- 2006-08-08 US US11/500,293 patent/US7317009B2/en not_active Expired - Fee Related
- 2006-08-18 HK HK06109178A patent/HK1088900A1/xx not_active IP Right Cessation
2007
- 2007-12-12 CY CY20071101578T patent/CY1107084T1/el unknown

Also Published As

Publication number	Publication date
PT1581535E (pt)	2007-12-12
AR042833A1 (es)	2005-07-06
BR0317358A (pt)	2005-12-13
DK1581535T5 (da)	2009-12-21
EP1581535A1 (en)	2005-10-05
ATE376549T1 (de)	2007-11-15
ES2291729T7 (es)	2010-03-31
KR20050092738A (ko)	2005-09-22
RU2328499C2 (ru)	2008-07-10
CY1107084T1 (el)	2012-10-24
US20050075342A1 (en)	2005-04-07
WO2004063197A1 (en)	2004-07-29
KR101026819B1 (ko)	2011-04-04
JP4671104B2 (ja)	2011-04-13
IL169500A0 (en)	2007-07-04
TWI332004B (en)	2010-10-21
ES2291729T3 (es)	2008-03-01
EP1581535B3 (en)	2009-09-02
DK1581535T3 (da)	2008-02-11
HK1088900A1 (en)	2006-11-17
MXPA05007462A (es)	2006-01-27
CA2513081A1 (en)	2004-07-29
US7317009B2 (en)	2008-01-08
RU2005125209A (ru)	2006-01-27
DE60317102T2 (de)	2009-01-29
NO20053748L (no)	2005-10-07
CA2513081C (en)	2011-04-19
NZ541232A (en)	2008-02-29
EP1581535B1 (en)	2007-10-24
DE60317102T3 (de)	2010-02-18
DE60317102D1 (de)	2007-12-06
US20060270678A1 (en)	2006-11-30
PL378245A1 (pl)	2006-03-20
US7153854B2 (en)	2006-12-26
JP2006515597A (ja)	2006-06-01
EP1581535B9 (en)	2008-03-19
TW200418861A (en)	2004-10-01

Publication	Publication Date	Title
NO20053748D0 (no)	2005-08-04	Pyrrolopyridazinderivater.
NO20032883L (no)	2004-12-24	Bolgekraftverk.
NO20041144L (no)	2004-09-22	Gassloftingsventil.
DK1594840T3 (da)	2007-02-05	Piperidin-benzensulfonamid-derivater
ATE420066T1 (de)	2009-01-15	Amidoacetonitrilderivate
ATE352550T1 (de)	2007-02-15	Chinazolinderivate
DK1606277T3 (da)	2008-08-18	Imidazol-4-yl-ethynyl-pyridinderivater
ATE354365T1 (de)	2007-03-15	N-thiazol-2-yl-benzamid-derivate
ATE449064T1 (de)	2009-12-15	Amidoacetonitrilderivate
FR2855029B1 (fr)	2006-04-07	Cache-pot.
NO20040394L (no)	2004-02-02	Fullpumpesentreringsstotte.
ES1054077Y (es)	2003-10-01	Pancarta plegable.
ITMI20031078A1 (it)	2004-11-30	Copridivano.
ITGE20030068A1 (it)	2005-03-06	Termoalgometro.
ES1055830Y (es)	2004-10-16	Mosquitera.
NL1026828A1 (nl)	2005-03-09	Derivaten van azachinazoline.
NO20040532L (no)	2004-08-09	Sammenleggbar minesoker.
ES1056384Y (es)	2004-07-01	Capazo-cuna.
ES1056074Y (es)	2004-06-01	Portarretratos.
ES1056135Y (es)	2004-06-01	Lava-pies.
ES1055888Y (es)	2004-05-16	Cuchara-pinza.
ES1055866Y (es)	2004-05-16	Mopa-fregona.
ES1055854Y (es)	2004-05-16	Colchon-reposapies.
ES1055973Y (es)	2004-06-01	Mechero piezo-electrico.
ES1055748Y (es)	2004-04-16	Portalamparas.